Phase I Pharmacokinetic and Pharmacodynamic Study of Cetuximab, Irinotecan and Sorafenib in Advanced Colorectal Cancer

BACKGROUND: This phase Ib study was designed to determine the maximum tolerated doses (MTD) and dose limiting toxicities (DLTs) of irinotecan and cetuximab with sorafenib. Secondary objectives included characterizing the pharmacokinetics and pharmacodynamics and evaluating preliminary antitumor acti...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Azad, Nilofer, Dasari, Arvind, Arcaroli, John, Taylor, Gretchen E., Laheru, Daniel A., Carducci, Michael A., McManus, Martine, Quackenbush, Kevin, Wright, John J., Hidalgo, Manuel, Diaz, Luis A., Donehower, Ross C., Zhao, Ming, Rudek, Michelle A., Messersmith, Wells A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2012
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3674958/
https://ncbi.nlm.nih.gov/pubmed/22615057
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10637-012-9820-z
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
Caricamento...

Documenti analoghi